logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by Carrie Markgraf MD PhD, Thomas Hudzik PhD, David Compton PhD DABT ISBN 9780124201729, 9780124202160, 0124201725, 0124202160

  • SKU: EBN-5432228
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

0.0

0 reviews
Instant download (eBook) Nonclinical Assessment of Abuse Potential for New Pharmaceuticals after payment.
Authors:Carrie Markgraf MD PhD, Thomas Hudzik PhD, David Compton PhD DABT
Pages:320 pages.
Year:2015
Editon:1
Publisher:Academic Press
Language:english
File Size:7.77 MB
Format:pdf
ISBNS:9780124201729, 9780124202160, 0124201725, 0124202160
Categories: Ebooks

Product desciption

(Ebook) Nonclinical Assessment of Abuse Potential for New Pharmaceuticals by Carrie Markgraf MD PhD, Thomas Hudzik PhD, David Compton PhD DABT ISBN 9780124201729, 9780124202160, 0124201725, 0124202160

Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug. By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability.
  • Provides a consolidated overview of the complex regulatory landscape
  • Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies
  • Includes real-life examples to illustrate how nonclinical data fit into the submission strategy
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products